Taylor, MJ, Freemantle, N, Geddes, JR, Bhagwagar, Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry
2006; 63: 1217–23.
Posternak, MA, Zimmerman, M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry
2005; 66: 148–58.
Harmer, CJ, Shelley, NC, Cowen, PJ, Goodwin, GM. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry
2004; 161: 1256–63.
Browning, M, Reid, C, Cowen, PJ, Goodwin, GM, Harmer, C. A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol
2007; 21: 684–90.
Harmer, CJ, Bhagwagar, Z, Perrett, DI, Vollm, BA, Cowen, PJ, Goodwin, GM. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology
2003; 28: 148–52.
Drevets, WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci
2003; 985: 420–44.
Sheline, YI, Barch, DM, Donnelly, JM, Ollinger, JM, Snyder, AZ, Mintun, MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry
2001; 50: 651–8.
Fu, CH, Williams, SC, Cleare, AJ, Brammer, MJ, Walsh, ND, Kim, J, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry
2004; 61: 877–89.
Harmer, CJ, Mackay, CE, Reid, CB, Cowen, PJ, Goodwin, GM. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry
2006; 59: 816–20.
Del-Ben, CM, Deakin, JF, McKie, S, Delvai, NA, Williams, SR, Elliott, R, et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology
2005; 30: 1724–34.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV Axis I Disorders (SCID–I). American Psychiatric Press, 1997.
Nelson, HE, Willison, J. National Adult Reading Test (NART). nferNelson, 1991.
Spielberger, CD, Gorsuch, RL, Lushene, RD. Manual for the State–Trait Anxiety Inventory (STAI). Consulting Psychologists Press, 1983.
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring depression. Arch Gen Psychiatry
1961; 4: 561–71.
von Zerssen, D, Strian, F, Schwarz, D. Evaluation of depressive states, especially in longitudinal studies. Mod Probl Pharmacopsychiatry
1974; 7: 189–202.
Watson, D, Clark, LA, Tellegen, A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol
1988; 54: 1063–70.
Ekman, P, Friesen, WV. Pictures of Facial Affect. Consulting Psychologists Press, 1976.
Jenkinson, M, Bannister, P, Brady, M, Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage
2002; 17: 825–41.
Smith, SM. Fast robust automated brain extraction. Hum Brain Mapp
2002; 17: 143–55.
Smith, S. A global optimisation method for robust affine registration of brain images. Med Image Anal
2001; 5: 143–56.
Beckmann, CF, Jenkinson, M, Smith, SM. General multilevel linear modeling for group analysis in FMRI. Neuroimage
2003; 20: 1052–63.
Woolrich, MW, Behrens, TE, Beckmann, CF, Jenkinson, M, Smith, SM. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage
2004; 21: 1732–47.
Worsley, KJ, Evans, AC, Marrett, S, Neelin, P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab
1992; 12: 900–18.
Talairach, J, Tournoux, P. Co-Planar Stereotactic Atlas of the Human Brain. Thieme, 1988.
Lancaster, JL, Woldroff, MG, Parsons, LM, Liotti, M, Freitas, CS, Rainey, L, et al. Automated Talairach atlas labels for function brain mapping. Hum Brain Mapp
2000; 10: 120–31.
Bhagwagar, Z, Cowen, PJ, Goodwin, GM, Harmer, CJ. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry
2004; 161: 166–8.
Mogg, K, Bradley, BP. A cognitive-motivational analysis of anxiety. Behav Res Ther
1998; 36: 809–48.
Morris, JS, Frith, CD, Perrett, DI, Rowland, D, Young, AW, Calder, AJ, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature
1996; 383: 812–5.
Drevets, WC, Videen, TO, Price, JL, Preskorn, SH, Carmichael, ST, Raichle, ME. A functional anatomical study of unipolar depression. J Neurosci
1992; 12: 3628–41.
Rauch, SL, Shin, LM, Wright, CI. Neuroimaging studies of amygdala function in anxiety disorders. Ann NY Acad Sci
2003; 985: 389–410.
Davidson, RJ, Irwin, W, Anderle, MJ, Kalin, NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry
2003; 160: 64–75.
Stutzmann, GE, LeDoux, JE. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci
1999; 19: RC8.
Drevets, WC, Bogers, W, Raichle, ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol
2002; 12: 527–44.
Kent, JM, Coplan, JD, Gorman, JM. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry
1998; 44: 812–24.
Burghardt, NS, Sullivan, GM, McEwen, BS, Gorman, JM, LeDoux, JE. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry
2004; 55: 1171–8.
Attenburrow, MJ, Williams, C, Odontiadis, J, Reed, A, Powell, J, Cowen, PJ, et al. Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology (Berl)
2003; 169: 104–7.
Neumeister, A, Hu, XZ, Luckenbaugh, DA, Schwarz, M, Nugent, AC, Bonne, O, et al. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry
2006; 63: 978–86.
Whalen, PJ, Rauch, SL, Etcoff, NL, McInerney, SC, Lee, MB, Jenike, MA. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci
1998; 18: 411–8.
Phillips, ML, Williams, LM, Heining, M, Herba, CM, Russell, T, Andrew, C, et al. Differential neural responses to overt and covert presentations of facial expressions of fear and disgust. Neuroimage
2004; 21: 1484–96.
Bishop, SJ, Duncan, J, Lawrence, AD. State anxiety modulation of the amygdala response to unattended threat-related stimuli. J Neurosci
2004; 24: 10364–8.
Pessoa, L, McKenna, M, Gutierrez, E, Ungerleider, LG. Neural processing of emotional faces requires attention. Proc Natl Acad Sci USA
2002; 99: 11458–63.
Wise, RG, Tracey, I. The role of fMRI in drug discovery. J Magn ResonImaging
2006; 23: 862–76.
Iannetti, GD, Wise, RG. BOLD functional MRI in disease and pharmacological studies: room for improvement?
Magn Reson Imaging
2007; 25: 978–88.